Protein Labelling Innovation Technologies

PLI Technologies uses an innovative, proprietary technology for uniform labelling with stable (non radio active) isotopes of a wide range of pro- and eukaryotic species. We offer labelled cell biomass, extracts and purified compounds. This technology allows cost-effective production of labelled biomolecules (from small metabolites up to large, including protein therapeutics or drug targets such as e.g. GPCRs) in insect and mammalian cell lines and can be used for 3D structure determination and in silico drug design.